3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lymphoma, Large B-Cell, Diffuse
18
Sarcoma
15
Burkitt Lymphoma
9
Breast Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasm Metastasis
8
Triple Negative Breast Neoplasms
7
Lymphoma, T-Cell, Peripheral
7
Lymphoma, Follicular
7
Lymphoma, B-Cell
7
Ovarian Neoplasms
6
Lymphoma
6
Hodgkin Disease
6
Endometrial Neoplasms
5
Osteosarcoma
4
Neuroblastoma
4
Lymphoma, Non-Hodgkin
4
Liposarcoma
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Peritoneal Neoplasms
3
Neoplasms
3
Leukemia, Biphenotypic, Acute
3
Leiomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Hemangiosarcoma
3
Colorectal Neoplasms
3
Uterine Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Interventions
bintrafusp alfa protein, human
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Tertiary Lymphoid Structures
×
Doxorubicin
×
Clear all
NCT04874311
2025-08-13
TRUST
Institut Bergonié
Phase 2
Recruiting
80 enrolled